| scholarly article | Q13442814 |
| P2093 | author name string | Smith CA | |
| Goodwin RG | |||
| Wiley SR | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3635-3639 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Reverse signaling via CD30 ligand. | |
| P478 | volume | 157 |
| Q33890754 | A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling' |
| Q30720500 | An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line |
| Q35460930 | Association of TNFSF8 polymorphisms with peripheral neutrophil count |
| Q36251308 | Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). |
| Q38950501 | CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas |
| Q37327528 | CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro |
| Q26859079 | CD30: from basic research to cancer therapy |
| Q33841251 | Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy |
| Q35674652 | Characterization of CD30/CD30L(+) Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis. |
| Q41149227 | Clinical targeting recombinant immunotoxins for cancer therapy |
| Q34032643 | Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue |
| Q36505738 | Deciphering CD30 ligand biology and its role in humoral immunity |
| Q35642843 | Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease |
| Q40870263 | Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. |
| Q88550353 | Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome |
| Q35788035 | Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms |
| Q26991848 | Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey |
| Q36371279 | Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus |
| Q35017864 | Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion |
| Q36381058 | Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand |
| Q41862930 | Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. |
| Q92844503 | Physiology and pathology of T-cell aging |
| Q24598872 | RANK is essential for osteoclast and lymph node development |
| Q64228473 | Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface |
| Q40398654 | Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells |
| Q91973455 | Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma |
| Q36380948 | T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus |
| Q35849294 | TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo |
| Q50293072 | TNFSF8 binds TNFRSF8 |
| Q60934870 | The impact of senescence-associated T cells on immunosenescence and age-related disorders |
| Q28362305 | Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells |
| Q33915940 | Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents |
| Q94546979 | Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer |
| Q36380499 | Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity |
Search more.